Other languages Orthocell Limited

Equities

Market Closed - Australian S.E. Other stock markets 06:05:57 14/05/2024 BST			5-day change	1st Jan Change
0.4 ^AUD	+2.56%		+6.67%	-2.44%

04:38am	Orthocell's Striate+ Dental Membrane Product Achieves 98.6% Success Rate in Post-Market Clinical Study; Shares Up 3%	MT
04-15	Orthocell Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 3%	MT

Orthocell's Striate+ Dental Membrane Product Achieves 98.6% Success Rate in Post-Market Clinical Study; Shares Up 3%	03:38am
Orthocell Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 3%	04-15
Orthocell Revenue Soars 19% to AU$1.61 Million in Q1	04-09
Orthocell Completes First Stage of Remplir US Market Authorization Study	03-24
Orthocell Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-23
Orthocell Completes AU$3.5 Million Share Placement	02-22
Orthocell Submits Regulatory Application for Remplir in Singapore	02-13
Orthocell Limited Announces Resignation of Matthew Callahan from the Board	01-15
Orthocell Limited Appoints Kim Beazley AC as an Independent Non-Executive Director	01-14
Orthocell Limited Announces Changes to its Board	12-21
Orthocell Limited Provides Commercial Revenue Guidance for the Full Year 2023	24/10/23
Orthocell Limited Announces Board Changes	24/10/23
Orthocell Limited Announces Board Changes	22/09/23
Orthocell Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Orthocell Limited Announces Board Changes	29/05/23
Orthocell Begins Comparator Study for Product Marketing Initiatives	18/04/23
Orthocell Limited Announces Appointments to its Medical and Scientific Advisory Board	28/03/23
Orthocell Limited Appoints Ravi I. Thadhani as Independent Non-Executive Director	07/03/23
Orthocell Announces Company Secretary Changes	28/02/23
Orthocell Limited Reports Earnings Results for the Half Year Ended December 31, 2022	28/02/23

No results for this search